Literature DB >> 11471107

Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.

P N Mwinzi1, D M Karanja, D G Colley, A S Orago, W E Secor.   

Abstract

In vitro studies suggest that CD4(+) cells with a T helper 2 (Th2) phenotype better support human immunodeficiency virus type 1 (HIV-1) replication than do cells of the Th1 phenotype. As a result, Th2-type immune responses may be substantially affected by HIV-1 coinfection. To test this hypothesis, a comparison was done of proliferation and cytokine production by peripheral blood mononuclear cells from patients with schistosomiasis who were positive or negative for HIV-1. Patients with schistosomiasis with HIV-1 coinfections had significantly lower interleukin (IL)-4 and IL-10 production than did HIV-1-negative individuals. In contrast, interferon-gamma production levels were similar between the 2 groups. Furthermore, in patients with HIV-1, a decrease in CD4(+) T cells was correlated with an increased Th1:Th2 cytokine production ratio. The effect of praziquantel treatment on proliferation and cytokine responses also differed between HIV-1 infection groups. Thus, HIV-1 infection affects immune response patterns of patients with schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11471107     DOI: 10.1086/322783

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Studies on parasitologic and haematologic activities of an enaminone derivative of 4-hydroxyquinolin-2(1H)-one against murine schistosomiasis mansoni.

Authors:  Amal M El-Shennawy; Amira H Mohamed; Mohamed Abass
Journal:  MedGenMed       Date:  2007-01-23

2.  Human tissue mast cells are an inducible reservoir of persistent HIV infection.

Authors:  J Bruce Sundstrom; Jane E Ellis; Gregory A Hair; Arnold S Kirshenbaum; Dean D Metcalfe; Hong Yi; Adriana C Cardona; Michael K Lindsay; Aftab A Ansari
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

3.  Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic.

Authors:  Cecilia T Costiniuk; Curtis L Cooper; Steve Doucette; Colin M Kovacs
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

4.  A new approach to characterize populations of Schistosoma mansoni from humans: development and assessment of microsatellite analysis of pooled miracidia.

Authors:  B Hanelt; M L Steinauer; I N Mwangi; G M Maina; L E Agola; G M Mkoji; E S Loker
Journal:  Trop Med Int Health       Date:  2009-01-28       Impact factor: 2.622

5.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

6.  Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(+) T cells and monocytes of patients with Schistosoma mansoni infection.

Authors:  W Evan Secor; Amil Shah; Pauline M N Mwinzi; Bryson A Ndenga; Caroline O Watta; Diana M S Karanja
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment.

Authors:  Kanji Watanabe; Pauline N M Mwinzi; Carla L Black; Erick M O Muok; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

8.  Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.

Authors:  Lisa M Ganley-Leal; Pauline N Mwinzi; Catherine B Cetre-Sossah; Julius Andove; Allen W Hightower; Diana M S Karanja; Daniel G Colley; W Evan Secor
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.

Authors:  Rbl Zinyama-Gutsire; E Gomo; P Kallestrup; C Erikstrup; H Ullum; A E Butterworth; S Munyati; T Mduluza
Journal:  BMC Infect Dis       Date:  2009-10-23       Impact factor: 3.090

10.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.